Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers

Kelly Anne Phillips, Roger L. Milne, Matti A. Rookus, Mary B. Daly, Antonis C. Antoniou, Susan Peock, Debra Frost, Douglas F. Easton, Steve Ellis, Michael L. Friedlander, Saundra S. Buys, Nadine Andrieu, Catherine Noguès, Dominique Stoppa-Lyonnet, Valérie Bonadona, Pascal Pujol, Sue Anne McLachlan, Esther M. John, Maartje J. Hooning, Caroline SeynaeveRob A.E.M. Tollenaar, David E. Goldgar, Mary Beth Terry, Trinidad Caldes, Prue C. Weideman, Irene L. Andrulis, Christian F. Singer, Kate Birch, Jacques Simard, Melissa C. Southey, Håkan L. Olsson, Anna Jakubowska, Edith Olah, Anne Marie Gerdes, Lenka Foretova, John L. Hopper

Research output: Contribution to journalArticle

125 Citations (Scopus)

Fingerprint Dive into the research topics of 'Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers'. Together they form a unique fingerprint.

Medicine & Life Sciences